Indeed, we have demonstrated that a cell permeable form of the P4 peptide, as well as the small compound UCS15A, effectively block AMAP1/cortactin binding and block breast cancer invasion and metastasis, while these blockers do not efficiently inhibit other canonical SH3/Pro bindings (45). The gene discussed is ASAP1; the disease is breast carcinoma.